Cargando…
First results about recovery of walking function in patients with intensive care unit-acquired muscle weakness from the General Weakness Syndrome Therapy (GymNAST) cohort study
OBJECTIVES: To describe the time course of recovery of walking function and other activities of daily living in patients with intensive care unit (ICU)-acquired muscle weakness. DESIGN: This is a cohort study. PARTICIPANTS: We included critically ill patients with ICU-acquired muscle weakness. SETTI...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691758/ https://www.ncbi.nlm.nih.gov/pubmed/26700274 http://dx.doi.org/10.1136/bmjopen-2015-008828 |
Sumario: | OBJECTIVES: To describe the time course of recovery of walking function and other activities of daily living in patients with intensive care unit (ICU)-acquired muscle weakness. DESIGN: This is a cohort study. PARTICIPANTS: We included critically ill patients with ICU-acquired muscle weakness. SETTING: Post-acute ICU and rehabilitation units in Germany. MEASURES: We measured walking function, muscle strength, activities in daily living, motor and cognitive function. RESULTS: We recruited 150 patients (30% female) who fulfilled our inclusion and exclusion criteria. The primary outcome recovery of walking function was achieved after a median of 28.5 days (IQR=45) after rehabilitation onset and after a median of 81.5 days (IQR=64) after onset of illness. Our final multivariate model for recovery of walking function included two clinical variables from baseline: the Functional Status Score ICU (adjusted HR=1.07 (95% CI 1.03 to 1.12) and the ability to reach forward in cm (adjusted HR=1.02 (95% CI 1.00 to 1.04). All secondary outcomes but not pain improved significantly in the first 8 weeks after study onset. CONCLUSIONS: We found good recovery of walking function for most patients and described the recovery of walking function of people with ICU-acquired muscle weakness. TRIALS REGISTRATIONS NUMBER: Sächsische Landesärztekammer EK-BR-32/13-1; DRKS00007181, German Register of Clinical Trials. |
---|